Business Wire

WALKOUT

9.12.2021 18:55:13 CET | Business Wire | Press release

Share
Machsanei Hashuk Integrates WalkOut’s Smart-cart Solution in All Its Branches

The Israeli company WalkOut , the developer of an autonomous end-to-end frictionless shopping solution, announces an extensive cooperation agreement with Machsanei Hashuk , one of the largest supermarket chains in Israel. As part of the agreement, the chain will implement the fully autonomous checkout solution, considered the most accurate in the world's retail industry, in all 62 of its branches. Its deployment will begin as early as next month.

Although 61 percent of shoppers would prefer to purchase brands that also have a physical location, over 70 percent of shoppers report that standing in line for checkouts is frustrating and detracts from the shopping experience. Until the development of WalkOut’s solution, no system has accompanied the customer throughout the entire purchase, which includes actual checkout.

WalkOut’s retrofit smartcart solution offers a revolution in the shopping experience that addresses two main challenges that marketing chains face in the physical buying process.
The first is related to waiting in long queues at the checkout. The second is the inability to create a personalized shopping experience for each customer.

The company’s first-ever truly seamless retrofitted solution in the retail industry requires no costly infrastructural changes to the store, while other solutions require the retailer to purchase new carts and most rely on barcode scanners and scales for item recognition. The mountable cart device's multiple high-precision cameras, which utilize many different proprietary algorithms to accurately recognize products, identify the items as shoppers load or remove them with 99.2 percent accuracy.

WalkOut’s edge computing and machine-vision algorithms also curtail the need for costly on-cloud servers and high-bandwidth internet support. This use of single-sensor architecture and edge-computing allows retail stores to operate a much more robust and cost-effective solution. Through a large touchscreen, the device also communicates with the customer to offer personalized recommendations, store navigation, supplementary product information, and relevant promotions based on the shopper's history and location in the store.

"Connecting to one of the largest retail chains in Israel is an exciting opportunity and an important milestone for us," says Assaf Gedalia, CEO and Co-Founder of WalkOut. “The solution is futuristic, personalized, and at the same time preserves the customer's privacy."

"As a chain that advocates innovative technologies, we wanted to offer our customers significant savings in waiting times at the checkouts and provide a more personal, accessible and efficient shopping experience," said Shalom Naaman, CEO and Owner of Machsanei Hashuk. "The WalkOut solution will significantly shorten the length of stay in the branches, help maximize our operational efficiency, and allow us to offer one of the most advanced shopping experiences in the world."

About WalkOut
WalkOut , founded in 2018, has set itself the goal of changing the way consumers purchase products in physical stores by placing the checkout directly on the shopping cart. The company's solution is based on machine vision technology capable of identifying any item placed or removed from the cart and calculating it in the final payment. In this way, the cart eliminates the need for a checkout and reduces the duration of the payment process to a minimum. The WalkOut solution includes a large touch screen located on the cart and combines a personalized shopping experience with offers and promotions based on each consumer's preferences, complementary products and the location of the products in the store. The WalkOut system is modular and can be installed on existing carts in stores without the need for significant changes on the part of the store.

About Machsanei Hashuk
Machsanei Hashuk is a leading marketing chain owned and managed by the Naaman & Cohen families that was first established in 1996 in the city of Beer Sheva. The chain currently has 62 branches nationwide from Safed to Eilat. In 2019, the chain acquired Co-op, and in doing so became one of the largest leading marketing chains in Israel. Co-op branches have since been converted into "Machsanei Hashuk sheli''. The chain operates an advanced and accessible online site, in addition to its branches. It also offers its own Wincard+ credit card, in cooperation with Max, which combines regular card rewards with the chain's own promotions. Machsanei Hashuk operates a strong and active customer club with more than 400,000 loyal customers.
The chain is the official sponsor of the football team "Hapoel Machsanei Hashuk Beer-Sheva.” For more information, visit https://www.mck.co.il/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye